Recombinogenicity and mutagenicity of saccharin in Saccharomyces cerevisiae

Mutat Res. 1979 Jul;67(3):215-9. doi: 10.1016/0165-1218(79)90015-6.

Abstract

Diploid yeast grown in the presence of a commercial lot of saccharin exhibited reproducible, dose-dependent increases in intergenic and intragenic recombination, and mutation. Cells grew to nearly the same titer in media without saccharin and containing 2 or 20 mg saccharin/ml, although cell viability was somewhat reduced in saccharin-containing media. At the high test dose of 100 mg/ml, titers and cell viability were more markedly lowered. Differences between this study and previous (negative) tests of saccharin in yeast are described.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Dose-Response Relationship, Drug
  • Mitosis
  • Mutation / drug effects*
  • Recombination, Genetic / drug effects*
  • Saccharin / pharmacology*
  • Saccharomyces cerevisiae / drug effects*
  • Saccharomyces cerevisiae / growth & development

Substances

  • Saccharin